← Back to Search

Dietary Supplement

AGY for Celiac Disease (AGY-010 Trial)

Phase 2
Waitlist Available
Led By Justine Turner, MD, PhD
Research Sponsored by Igy Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 weeks
Awards & highlights

AGY-010 Trial Summary

This trial is testing a new drug for celiac disease to see if it is safe and effective.

AGY-010 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
symptoms

Side effects data

From 2015 Phase 1 trial • 10 Patients • NCT01765647
70%
conjestion or sore throat
70%
abdominal discomfort
60%
headache
40%
muscle discomfort
30%
cold symptoms
20%
eczema
20%
itchy or red eyes
10%
tiredness
10%
menstrual cramps
10%
sore ear
10%
sphincter of oddi syndrome
100%
80%
60%
40%
20%
0%
Study treatment Arm
AGY: Anti-gliadin Antibody for Celiac Disease

AGY-010 Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AGYExperimental Treatment1 Intervention
capsule containing egg yolk with AGY
Group II: placeboPlacebo Group1 Intervention
capsule containing plain egg yolk
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AGY
2014
Completed Phase 2
~180

Find a Location

Who is running the clinical trial?

Vetanda Group LtdUNKNOWN
VetandaUNKNOWN
Igy Inc.Lead Sponsor
1 Previous Clinical Trials
10 Total Patients Enrolled
1 Trials studying Celiac Disease
10 Patients Enrolled for Celiac Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial have an age limit and, if so, what is it?

"People aged 10 to 65 who meet the other inclusion criteria can apply for this clinical trial. There are 13 similar trials for people under 18 and 23 for senior citizens."

Answered by AI

What are the potential side effects of AGY?

"AGY falls into the Phase 2 category, which suggests that while there is some data affirming its safety, none yet exists to show that it is an effective medication."

Answered by AI

Are there any prerequisites for enrollment in this trial?

"This gluten-free clinical trial is testing a new medication for celiac disease. To be eligible, patients must be between the ages of 10-65. Right now, they are looking to enroll 149 people in total."

Answered by AI

Are we still looking for volunteers for this research project?

"Yes, the information available on clinicaltrials.gov indicates that this study is currently looking for 149 individuals to fill 1 vacant position(s). The posting went up on 10/29/2019 and has since been updated on the same date."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
How old are they?
< 18
18 - 65
What site did they apply to?
University of Alberta
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease
2019. "A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03707730.
~30 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top